Yoo Deok-Sang, Chang Jane, Kim Joon-Tae, Choi Min-Ji, Choi Jina, Choi Kang-Ho, Park Man-Seok, Cho Ki-Hyun
Department of Neurology, Cerebrovascular Center, Chonnam National University Hospital, Gwangju, Korea.
PLoS One. 2014 Apr 18;9(4):e94364. doi: 10.1371/journal.pone.0094364. eCollection 2014.
Hyperglycemia is common after stroke, and it is well known to worsen its outcome. However, it is important to consider that blood glucose (BG) levels can undergo dynamic changes during the acute stage of ischemic stroke. We sought to investigate the clinical significance of various glucose parameters within first 24 hours in acute ischemic stroke (AIS). The study focused on hyperacute stage patients who underwent IVT and investigated which parameters of glucose demonstrated to be helpful for predicting outcome.
This was a retrospective study of consecutive patients with AIS at a single stroke center. Patients were consecutively enrolled if they were treated with IV-tPA within 3 hours of symptom onset. BG was measured immediately upon arrival in ER, after IVT and every 6-8 hours during the first 24 hours after IVT. The various parameters of BG were the following: BG before IVT, BG after IVT, mean BG (mBG), maximal BG (max BG), standard deviation of BG (sdBG), and standard deviation of mean BG (sdmBG).
207 patients (127 men and 80 women) were included in this study. Seventy seven of 207 patients had favorable outcomes at 3 months. High BG after IVT, mBG and max BG were independently associated with mRS>2 at 3 months (adjusted by age, NIHSS, and atrial fibrillation). Several parameters of BG were also independently associated with early mortality within 3 months (BG after IVT, mBG, and max BG). BG after IVT and mBG over 180 mg/dL were independently associated with early mortality within 3 months.
Serial measurements of BG might be a better predictor of clinical outcome in patients with AIS treated with IVT than single BG measurements before IVT. Therefore, these results suggest that variable parameters of BG could be important for the prediction of clinical outcome in AIS treated with IVT.
卒中后高血糖很常见,且众所周知会使预后恶化。然而,重要的是要考虑到在缺血性卒中急性期血糖(BG)水平会发生动态变化。我们试图研究急性缺血性卒中(AIS)发病后24小时内各种血糖参数的临床意义。该研究聚焦于接受静脉溶栓治疗(IVT)的超急性期患者,并研究哪些血糖参数有助于预测预后。
这是一项在单一卒中中心对连续性AIS患者进行的回顾性研究。如果患者在症状发作后3小时内接受静脉注射重组组织型纤溶酶原激活剂(IV-tPA)治疗,则连续纳入研究。患者到达急诊室后立即测量BG,静脉溶栓治疗后测量,以及在静脉溶栓治疗后的头24小时内每6 - 8小时测量一次。BG的各种参数如下:静脉溶栓治疗前的BG、静脉溶栓治疗后的BG、平均BG(mBG)、最大BG(max BG)、BG的标准差(sdBG)以及平均BG的标准差(sdmBG)。
本研究纳入了207例患者(127例男性和80例女性)。207例患者中有77例在3个月时预后良好。静脉溶栓治疗后的高BG、mBG和max BG与3个月时改良Rankin量表(mRS)评分>2独立相关(根据年龄、美国国立卫生研究院卒中量表(NIHSS)和心房颤动进行校正)。BG的几个参数也与3个月内的早期死亡率独立相关(静脉溶栓治疗后的BG、mBG和max BG)。静脉溶栓治疗后的BG和超过180 mg/dL的mBG与3个月内的早期死亡率独立相关。
对于接受静脉溶栓治疗的AIS患者,连续测量BG可能比静脉溶栓治疗前单次测量BG更能预测临床结局。因此,这些结果表明BG的可变参数对于接受静脉溶栓治疗的AIS患者临床结局的预测可能很重要。